Donor CYP3A5 genotype influences tacrolimus disposition on the first day after paediatric liver transplantation.

about

Donor CYP3A5 genotype influences tacrolimus disposition on the first day after paediatric liver transplantation.

Item

http://www.wikidata.org/entity/Q55129457

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Donor CYP3A5 genotype influenc ...... diatric liver transplantation.

@en

Donor CYP3A5 genotype influenc ...... diatric liver transplantation.

@nl

type

Item

label

Donor CYP3A5 genotype influenc ...... diatric liver transplantation.

@en

Donor CYP3A5 genotype influenc ...... diatric liver transplantation.

@nl

prefLabel

Donor CYP3A5 genotype influenc ...... diatric liver transplantation.

@en

Donor CYP3A5 genotype influenc ...... diatric liver transplantation.

@nl

P1476

Donor CYP3A5 genotype influenc ...... ediatric liver transplantation

@en

P2093

Andrea Brunati

http://www.w3.org/2001/XMLSchema#string

Antonello Nonnato

http://www.w3.org/2001/XMLSchema#string

Carlo Ferretti

http://www.w3.org/2001/XMLSchema#string

Daniela Bongioanni

http://www.w3.org/2001/XMLSchema#string

Dominic Dell' Olio

http://www.w3.org/2001/XMLSchema#string

Francesco Tandoi

http://www.w3.org/2001/XMLSchema#string

Giulia Carbonaro

http://www.w3.org/2001/XMLSchema#string

Loredana Serpe

http://www.w3.org/2001/XMLSchema#string

Mauro Salizzoni

http://www.w3.org/2001/XMLSchema#string

Michele Pinon

http://www.w3.org/2001/XMLSchema#string

P2860

The Concise Guide to PHARMACOLOGY 2015/16: Enzymes

The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

Growth factors in children with end-stage liver disease before and after liver transplantation: a review.

Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Addressing phenoconversion: the Achilles' heel of personalized medicine.

Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs

Ontogeny of drug metabolizing enzymes in the neonate.

Hormonal effects on drug metabolism through the CYP system: perspectives on their potential significance in the era of pharmacogenomics.

Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A-status in liver transplant patients.

Inherent sex-dependent regulation of human hepatic CYP3A5

P304

1252-1262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.13219

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pier Luigi Calvo

Antonio Amoroso

P577

2017-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28044353

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation

P932

5427244

http://www.w3.org/2001/XMLSchema#string